Cargando…
Differential Impact of Serial Measurement of Nonplatelet Thromboxane Generation on Long‐Term Outcome After Cardiac Surgery
BACKGROUND: Systemic thromboxane generation, not suppressible by standard aspirin therapy and likely arising from nonplatelet sources, increases the risk of atherothrombosis and death in patients with cardiovascular disease. In the RIGOR (Reduction in Graft Occlusion Rates) study, greater nonplatele...
Autores principales: | Kakouros, Nikolaos, Gluckman, Tyler J., Conte, John V., Kickler, Thomas S., Laws, Katherine, Barton, Bruce A., Rade, Jeffrey J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721801/ https://www.ncbi.nlm.nih.gov/pubmed/29097390 http://dx.doi.org/10.1161/JAHA.117.007486 |
Ejemplares similares
-
Risk Factors for Nonplatelet Thromboxane Generation After Coronary Artery Bypass Graft Surgery
por: Kakouros, Nikolaos, et al.
Publicado: (2016) -
Human Thromboxane A(2) Receptor Genetic Variants: In Silico, In Vitro and “In Platelet” Analysis
por: Gleim, Scott, et al.
Publicado: (2013) -
Correction: Human Thromboxane A(2) Receptor Genetic Variants: In Silico, In Vitro and “In Platelet” Analysis
por: Gleim, Scott, et al.
Publicado: (2013) -
Thromboxane generation by human peripheral blood polymorphonuclear leukocytes
Publicado: (1978) -
Thromboxane generation by human monocytes enhances platelet function
Publicado: (1986)